SMCHD1 and facioscapulohumeral muscular dystrophy: These findings are encouraging for the further exploration into FSHD therapies aimed at modulating SMCHD1 levels, as these studies point to a relatively minimal number of autosomal loci outside the D4Z4 repeat array that are strongly influenced by SMCHD1 levels.